Back to Invesco Ltd. Invesco Ltd.

TBPHTBPH
22 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in THERAVANCE BIOPHARMA INC

Invesco Ltd. holds 409,435 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $6.6M as of 2026-Q1. The position was increased (+130.1% shares). TBPH represents 0.0% of Invesco Ltd.'s portfolio.

Current Value

$6.6M

Current Shares

409,435

Total Value Change

+$6.5M

Total Shares Change

+399,402

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
409,435
+130.1%
$6.6M0.0%$13.96
44
2025-Q4
Increased
177,946
+622.2%
$3.3M0.0%$18.91
43
2025-Q3
Decreased
24,640
-2.7%
$359,7440.0%$14.43
0
2025-Q2
Increased
25,324
+12.4%
$279,3250.0%$11.22
18
2025-Q1
Decreased
22,535
-51.1%
$201,2380.0%$9.23
0
2024-Q4
Increased
46,050
+3.5%
$433,3310.0%$9.47
25
2024-Q3
Increased
44,474
+0.8%
$358,4600.0%$8.10
24
2024-Q2
Decreased
44,123
-65.0%
$374,1630.0%$8.48
0
2024-Q1
Increased
125,901
+94.6%
$1.1M0.0%$8.97
40
2023-Q4
Decreased
64,686
-38.0%
$727,0700.0%$11.24
0
2023-Q3
Increased
104,381
+97.5%
$900,8080.0%$8.63
40
2023-Q2
Increased
52,851
+0.7%
$547,0090.0%$10.30
24
2023-Q1
Increased
52,502
+83.6%
$569,6470.0%$10.73
38
2022-Q4
Decreased
28,602
-1.7%
$320,9150.0%$11.22
0
2022-Q3
Increased
29,098
+10.7%
$296,0000.0%$10.11
26
2022-Q2
Increased
26,281
+1.4%
$238,0000.0%$8.84
23
2022-Q1
Increased
25,908
+0.7%
$248,0000.0%$9.47
23
2021-Q4
Decreased
25,729
-5.6%
$284,0000.0%$10.98
0
2021-Q3
Increased
27,252
+24.9%
$202,0000.0%$7.44
28
2021-Q2
Increased
21,812
+77.3%
$317,0000.0%$15.01
36
2021-Q1
Increased
12,304
+22.6%
$251,0000.0%$20.64
28
2020-Q4
New
10,033
-
$179,0000.0%$17.66
31

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used